Genetic heterogeneity of diffuse large B-cell lymphoma - Wikidata - wikimedia - TriplyDB

Genetic heterogeneity of diffuse large B-cell lymphoma

Genetic heterogeneity of diffuse large B-cell lymphoma

http://www.wikidata.org/entity/Q36567845

about

BJAB Farage HT Karpas-422 OCI-Ly1 OCI-Ly10 OCI-Ly19 OCI-Ly3 OCI-Ly7 OCI-Ly8 Pfeiffer RC-K8 RL Sc-1 SKI-DLCL-1 SU-DHL-4 SU-DHL-7 TMD8 Toledo U-2932 WSU-NHL

P1343

Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies MEF2 transcription factors: developmental regulators and emerging cancer genes Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas Next-generation prognostic assessment for diffuse large B-cell lymphoma The epigenetic basis of diffuse large B-cell lymphoma Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma SWI/SNF chromatin remodeling complexes and cancer Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.The role of aberrant proteolysis in lymphomagenesis Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma Age-related clonal hematopoiesis associated with adverse outcomes Nature and importance of follicular lymphoma precursors.The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.Socioeconomic disparities in lymphoma Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL Mutational analysis of primary central nervous system lymphoma.Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility.Identification and analysis of driver missense mutations using rotation forest with feature selection.Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response.Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.TET proteins and the control of cytosine demethylation in cancer.The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patients Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis Protein domain-level landscape of cancer-type-specific somatic mutations.

P2860

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

P1343

Q26744080-673F8E86-B6F7-4A4A-AA54-1F5A5FAEBF8D Q26778515-82310121-4977-42AB-BB54-6C4D903342B3 Q26782506-4D086398-EE0A-4474-9851-92D7555553E8 Q26796428-B4846235-499D-41B4-BCA4-7E22867D7A49 Q26852288-0466D65D-E757-4C5F-A609-E3A386E0A106 Q26865645-2BC1828C-6055-423A-AB98-9F181358A00E Q26998657-DFDD1A05-52D6-49F1-99E7-1E74D781A7F5 Q27304386-8CE8C6BE-D8F6-4A66-A8AB-7EEDC29A20BD Q27852958-BC1F5603-1ABE-4BF3-95AE-62CBBFF76E3F Q28084404-95CAA9AD-ADA1-4327-9759-A263BD300315 Q28115493-16E458EC-55E3-498A-B105-8B36B1232BC8 Q28115962-64FBAE49-4BE1-4E75-989D-8584A826673A Q28386602-DBFFC56A-DB73-44B9-A2D1-F025C8FFAC43 Q33558757-0FF04246-93AB-4563-B79A-EEEA75EF4680 Q33585273-78689BF7-2B57-44F5-86EF-166F03459EBB Q33601156-5852383A-9982-44C6-82CC-C63EB98696EF Q33622342-4D2DA7A3-580E-4FC1-BCF1-90CF01156CDF Q33632104-C50FA7F2-15C4-409E-AEA8-CD14BA8D467C Q33687549-318C1DEE-A6C3-48D2-A557-19FB1E70F963 Q33718800-35E5AA36-2E06-4530-9ED5-37A4C51CB57E Q33851726-B8E6ABD3-8BBE-4EEC-A14E-8CE383706B7F Q34100855-36DD3F94-5E87-4965-BBAE-FE34B0EB54CF Q34104139-FAEB9FCB-8E6D-4F84-97FD-81F715F5A309 Q34155068-0133899B-D995-40E9-AA9B-9A7AE76184F8 Q34177518-A3516196-C358-47AE-971F-8AC51391CD0D Q34302170-95E20CAA-CA69-4639-967B-ED06F0D8D84C Q34353717-E17D6F24-50C7-44CF-805B-593DFF9741C2 Q34366539-6489BEA2-2529-451A-B11A-4A1764B8C5D4 Q34481343-D4B202F9-F672-4A33-BE0A-01445712F4B3 Q34494007-88B5BDB7-4394-4777-80E9-B0604E52FE52 Q34617849-B3DAA8DB-334B-44AA-BF5E-DCA2893833A6 Q34646755-20E8160E-9C97-4247-B2B9-137B7E667E32 Q34695303-BB445649-6C12-4B1C-BB69-F2C553439EC2 Q34714068-BBA04AC1-1861-4492-9673-58FDD113F56F Q34775356-184A27BB-2289-4664-B94E-019C27882ED4 Q34860750-DDC836FD-AEF8-48E9-B719-D155A1684EE6 Q35021377-59B016B1-753A-455D-B1B7-65A7C2EFB444 Q35078037-71F427EF-6300-41F7-9CA1-7B90CA52C506 Q35079601-55DA2467-7E52-4D80-A47A-AE74553F2EC4 Q35203134-37408BAF-AFF9-49AD-94CF-A7FFD298D5B7

P2860

Genetic heterogeneity of diffuse large B-cell lymphoma

http://www.wikidata.org/entity/Q36567845

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Genetic heterogeneity of diffuse large B-cell lymphoma

@ast

Genetic heterogeneity of diffuse large B-cell lymphoma

@en

type

label

Genetic heterogeneity of diffuse large B-cell lymphoma

@ast

Genetic heterogeneity of diffuse large B-cell lymphoma

@en

prefLabel

Genetic heterogeneity of diffuse large B-cell lymphoma

@ast

Genetic heterogeneity of diffuse large B-cell lymphoma

@en

P1433

Q36567845-2876587D-0DE9-49F2-8581-353120A34874

P1476

Q36567845-6DB9ED14-11DE-404B-8993-577F5C39AADA

P2093

Q36567845-01EF3B8D-3F2C-4731-A64F-6A143DE6EC24

Q36567845-03A039C8-EB1D-4682-91BA-164C8F85729A

Q36567845-15506822-9A4E-487C-9679-3A5BEDC0EEA3

Q36567845-2075977F-66D7-44D9-8E40-9D638378F873

Q36567845-2F44E150-9E83-427F-BCD0-C3B3A0B1A18A

Q36567845-3D354AA7-E127-49C3-9695-0670DB6ECA73

Q36567845-3E54EA99-7562-4326-8C1A-2396098D17E8

Q36567845-41A1C712-8DAF-4075-8734-9F001F387BAB

Q36567845-4C18DCEF-2AD1-4BB1-A50A-601A8DB442DB

Q36567845-5120C905-3BD0-49EC-A305-B15CB0207514

P2860

Q36567845-066959B6-2F94-4AD4-BF7D-A6C28BD1CB6A

Q36567845-09BA9711-E146-4683-B482-09B5BA662C4D

Q36567845-0F29F0C9-B410-454B-93F2-00A1A46E40A2

Q36567845-1248BFEC-5C14-4D8F-B236-4D846B026228

Q36567845-12A6BB66-9B65-4F31-83B6-3E7D06D2B438

Q36567845-170CC8CC-A347-4CEA-8B76-9A1F51AC5B3E

Q36567845-203DEB31-7DF4-47FF-8987-9082D4954D58

Q36567845-20603C25-094C-49E5-AE43-A2D71D9C4327

Q36567845-285883B8-3FE9-4044-A2FB-21E222F98410

Q36567845-43F60FAF-5805-416F-8F19-E5958CFE7680

P304

Q36567845-5652ABF0-18A7-44E1-9228-E8A54A93EBFA

P31

Q36567845-4072EFCD-8353-4235-9968-E4808BE77EBA

P356

Q36567845-F3C64C1E-4A95-4067-8094-C6151F4E6D74

P407

Q36567845-D09474A4-2DD6-469F-A715-8FCBC896C690

P433

Q36567845-0606B8E1-23EA-4DA9-8157-BDBC60E74EFD

P4510

Q36567845-03F3ED93-FF2F-4912-B11E-662F8DB1AE48

Q36567845-1D299396-85FB-41BD-A668-3EC317AE60B4

Q36567845-35164347-63DE-4E94-8477-62652E376D55

Q36567845-377E1274-2C35-44C0-BE16-A308C6296E21

Q36567845-4DA43B19-2E84-4BC8-AC6A-C3456CAFE89E

Q36567845-5BE583AA-3B3E-4A7E-AA01-3D6C09235B55

Q36567845-6984D5BD-A937-4989-B948-BF3DA70A56D3

Q36567845-6EB59E60-324C-4FA2-A818-1AA20E585E69

Q36567845-77619E84-3C76-46CA-8132-19F5D1A210AE

Q36567845-77AA11DF-97C2-4139-AE94-0363B0264DFC

P478

Q36567845-0B4DF626-AAA7-499D-B745-610469BCCF00

P50

Q36567845-1C8EDD92-9EE5-43CB-BCC2-3A165C1D07B3

Q36567845-7827E449-B988-4CBB-AD49-EF8F55F83EE5

Q36567845-80C86A8A-D180-441D-84FF-810D27205655

Q36567845-8D12F831-4E1E-4ABE-90E8-E6B68EEF4F59

Q36567845-BB5E81D9-84DB-49B8-98A9-D7636BA022B9

Q36567845-E9C19DCA-4B73-4C84-AFF0-3D18093E85C2

Q36567845-ECE68CE5-F98E-4A30-9D9D-8694F21E856F

P577

Q36567845-49E7DEB5-6D11-45B5-860C-8FC1A1CA7F5F

P5875

Q36567845-B6CEE78B-474F-4CBB-87DD-2EB75BA21CC9

P698

Q36567845-5A909B74-D6F8-4912-B515-C969B7614924

P921

Q36567845-91F5961F-13FC-4D19-A6E2-B2C9DE4F11A6

P932

Q36567845-68F8E37C-627E-47CD-B407-4A31C2854FBB

P356

PNAS.1205299110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Genetic heterogeneity of diffuse large B-cell lymphoma

@en

P2093

Alice Fan

http://www.w3.org/2001/XMLSchema#string

Amy Chadburn

http://www.w3.org/2001/XMLSchema#string

Amy J Johnson

http://www.w3.org/2001/XMLSchema#string

Anand S Lagoo

http://www.w3.org/2001/XMLSchema#string

Anjishnu Banerjee

http://www.w3.org/2001/XMLSchema#string

Cassandra L Love

http://www.w3.org/2001/XMLSchema#string

Cherie Dunphy

http://www.w3.org/2001/XMLSchema#string

Christopher Flowers

http://www.w3.org/2001/XMLSchema#string

David A Rizzieri

http://www.w3.org/2001/XMLSchema#string

David Dunson

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Gene ontology: tool for the unification of biology

KEGG: kyoto encyclopedia of genes and genomes

Sequencing of 50 human exomes reveals adaptation to high altitude

A small-cell lung cancer genome with complex signatures of tobacco exposure

dbSNP: the NCBI database of genetic variation

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Targeted capture and massively parallel sequencing of 12 human exomes

Initial genome sequencing and analysis of multiple myeloma

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

P304

1398-1403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1205299110

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P4510

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Kikkeri N Naresh

Piotr A Mieczkowski

P577

2013-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234070617

http://www.w3.org/2001/XMLSchema#string

P698

23292937

http://www.w3.org/2001/XMLSchema#string

P921

P932

3557051

http://www.w3.org/2001/XMLSchema#string